Conmed (CNMD) Misses Q1 EPS by 21c, provides guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $45.37 -0.94%
EPS Growth %: -7.4%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
LGCY, UXIN, SCHL, More
EPS Growth %: -7.4%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.79, $0.21 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $321.3 million versus the consensus estimate of $332.91 million.
GUIDANCE:
Conmed sees FY2025 EPS of $4.45-$4.60, versus the consensus of $4.34. Conmed sees FY2025 revenue of $1.35-1.378 billion, versus the consensus of $1.357 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and memory not a classic bubble, but future returns uncertain - strategist
- TPG RE Finance Trust Inc. (TRTX) 2200 contracts of January 7 puts trade, share price down 2.4%
- UBS Mulls Merger With Foreign Bank - Semafor
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
